Page 439 - The Vasculitides, Volume 1: General Considerations and Systemic Vasculitis

Index 413

PBMC, 264 plasma cells, 20, 27, 40, 42, 43, 48, 60, 344, 389
PCA, 36, 38, 39 plasma membrane, 102, 184
PCP, 169, 328 plasma proteins, 374
PCR, 45, 46, 229 plasmapheresis, 26, 266, 351, 352, 353
PCT, 233 plasminogen, 248, 256
pedigree, 166 platelet aggregation, 184
penetrance, 166 platelet count, 335
penicillin, 25 platelets, 103
peptidase, 75, 101 platform, 98, 106
peptide(s), 75, 177, 186, 234, 235, 265, 273 platinum, 222
perforation, 181, 210, 216, 242, 278, 285, 286, 288, pleura, 241, 248, 253
pleural effusion, 242, 246, 249, 250, 251
289, 290, 293, 295, 348 pleurisy, 299, 301
perfusion, 45, 49, 250, 257, 281, 340, 353 pleuritis, 349
pericarditis, 22, 181, 285, 298, 299, 301 plexus, 44, 370
pericardium, 6, 222 PLP, 45
peripheral blood, 164, 177, 186, 187, 197, 264, 290 PM, 221, 295, 368, 396
peripheral blood mononuclear cell, 264 pneumonia, 169, 180, 182, 215, 223, 248, 250, 253,
peripheral nervous system, x, 58, 61, 204, 206, 301,
257, 298
352 pneumonitis, 22
peripheral neuritis, 20 pneumothorax, 242, 251, 256
peripheral neuropathy, 20, 21, 22, 23, 29, 30, 33, 44, policy, 156, 157, 159
polio, 169
61, 148, 168, 172, 205, 206, 212, 228, 230, 236, polyacrylamide, 228
299, 301 Polyarteritis nodosa, 11, 16, 51, 67, 81, 125, 191,
peritoneum, 6
peritonitis, 25, 211 199, 219, 221, 222, 223, 225, 279, 293, 362, 379,
permeability, 137, 206 395
permission, 19, 21, 40, 41, 124, 131, 384 polymerase, 46, 229
Peru, 25, 54, 116, 366 polymerase chain reaction, 46, 229
PET, 19, 20, 43, 45, 46, 167, 281, 320, 322, 332 polymerization, 195
petechiae, 29, 232, 303, 369, 370, 376, 383, 389 polymers, 182, 192
PGN, 230 polymorphism(s), 46, 68, 74, 79, 94, 96, 98, 99, 100,
phagocytosis, 69, 75 101, 102, 103, 104, 105, 106, 108, 109, 110, 111,
phalanges, 382 112, 113, 114, 115, 116, 117, 118, 119, 120, 182,
pharmacokinetics, 61 191, 192, 228, 267, 274
pharmacotherapy, 282 polymyalgia rheumatica, 68, 78, 79, 80, 107, 108,
pharynx, 286 109, 110, 126, 220, 292, 312, 326, 327, 328, 329,
phenotype(s), vii, 24, 66, 85, 86, 90, 91, 95, 96, 104, 330, 331, 332, 333, 334
115, 122, 131, 229, 394 polypeptide, 97, 100
Philadelphia, 12, 307, 358, 360 polysaccharide, 169
phlebitis, 34, 43, 137, 355 population control, 32, 302, 312
phosphate, 184, 185 porphyria, 233
phospholipids, 31 positive correlation, 98
photophobia, 27, 167, 350, 351, 352, 354, 356 positron, 19, 46, 167, 281, 320, 332
photosensitivity, 354, 380, 381 positron emission tomography, 19, 46, 167, 281,
physical therapy, 216 320, 332
physicians, 25 prednisone, 23, 24, 27, 29, 33, 40, 45, 46, 48, 169,
Physiological, 12 217, 243, 306, 322, 323, 324, 332, 334, 340, 348,
PI3K, 185 352, 353, 354, 355
pigmentation, 374 pregnancy, 171, 174
pilot study, 48, 305, 308 preparation, 78, 290
placebo, 295, 306, 324, 332, 333, 334 prescription drugs, 164, 266
placenta, 171 preservation, 174
plaque, 170

Complimentary Contributor Copy